Abstract
Plasma microRNA (miRNA) levels may be altered during pathological processes; therefore, they may potentially serve as biomarkers for the diagnosis and prognosis of human diseases. This study aimed to explore whether plasma miRNAs may serve as new biomarkers for liver injury among chronic hepatitis B (CHB) patients with normal or nearly normal alanine aminotransferase (ALT) levels.
Funding Information
  • National Science and Technology Major Project (2012ZX10002004-001)
  • Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81121002)

This publication has 31 references indexed in Scilit: